AZD-4017 Uses, Dosage, Side Effects and more
AZD-4017 is under investigation in clinical trial NCT01173471 (A Phase IIa Study to Assess the Tolerability, Safety, and Efficacy of AZD4017 for Raised Intra-ocular Pressure).
| Trade Name | AZD-4017 |
| Generic | AZD-4017 |
| Type | |
| Formula | C22H33N3O3S |
| Weight | Average: 419.581 Monoisotopic: 419.224262627 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
